Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events.

Current drug safety

Volumn 3, Issue 2, 2008, Pages 143-153

  Wernicke, Joachim ^a   Acharya, Nayan ^a   Strombom, Indiana ^a   Gahimer, James L ^a   D'Souza, Deborah N ^a   DiPietro, Natalie ^a   Uetrecht, Jack P ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; DULOXETINE; SEROTONIN UPTAKE INHIBITOR; THIOPHENE DERIVATIVE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHEMICALLY INDUCED DISORDER; CHILD; DOSE RESPONSE; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; LIVER; LIVER DISEASE; MALE; MIDDLE AGED; REVIEW; RISK ASSESSMENT; SAFETY; SEX RATIO;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CONSUMER PRODUCT SAFETY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; SEX DISTRIBUTION; THIOPHENES; YOUNG ADULT;

EID: 66749119940     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488608784529198     Document Type: Review

References (30)